Multidisciplinary evaluation of Clostridium butyricum clonality isolated from preterm neonates with necrotizing enterocolitis in South France between 2009 and 2017.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
14 02 2019
Historique:
received: 12 10 2018
accepted: 12 12 2018
entrez: 16 2 2019
pubmed: 16 2 2019
medline: 12 9 2020
Statut: epublish

Résumé

The association between Clostridium species identification from stool samples in preterm neonates and the occurrence of necrotizing enterocolitis has been increasingly reported. To confirm the specific impact of Clostridium butyricum in this pathology, selective culture procedure was used for Clostridia isolation. Whole-genome analysis was employed to investigate genomic relationships between isolates. Stool samples from present study, as well as from previously investigated cases, were implicated including 88 from preterm neonates with necrotizing enterocolitis and 71 from matched controls. Quantitative real-time polymerase chain reaction was performed to evaluate the presence of C. butyricum from stools of new cases. Clostridium species prevalence isolated by culture was compared between patients with necrotizing enterocolitis and controls. By combining results of both culture and quantitative polymerase chain reaction methods, C. butyricum was significantly more frequent in stool samples from preterm neonates with necrotizing enterocolitis than in controls. Whole-genome analysis of 81 genomes including 58 neonates' isolates revealed that cases were clustered depending on geographical origin of isolation. Controls isolates presented genomic relations with that of patients suggesting a mechanism of asymptomatic carriage. Overall, this suggests an epidemiology comparable to that observed in Clostridium difficile colitis in adults.

Identifiants

pubmed: 30765857
doi: 10.1038/s41598-019-38773-7
pii: 10.1038/s41598-019-38773-7
pmc: PMC6376027
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2077

Références

Future Microbiol. 2016;11(2):273-92
pubmed: 26855351
Semin Perinatol. 2017 Feb;41(1):29-35
pubmed: 27986328
J Perinatol. 2017 Jan;37(1):67-72
pubmed: 27684417
New Microbes New Infect. 2016 Sep 25;14:85-92
pubmed: 27818774
Anaerobe. 2016 Feb;37:13-24
pubmed: 26596863
Lancet Infect Dis. 2017 Feb;17(2):207-214
pubmed: 27863959
Microb Genom. 2016 Apr 29;2(4):e000056
pubmed: 28348851
Clin Infect Dis. 2016 Apr 1;62(7):863-870
pubmed: 26787171
Pediatr Res. 2007 Jan;61(1):37-41
pubmed: 17211138
Acta Paediatr. 2016 Jun;105(6):e240-6
pubmed: 26946352
Acta Paediatr. 2018 Jan;107(1):40-47
pubmed: 28921627
Clin Infect Dis. 2015 Oct 1;61(7):1107-15
pubmed: 26084844
N Engl J Med. 2013 Sep 26;369(13):1195-205
pubmed: 24066741
J Pediatr. 1990 Jul;117(1 Pt 2):S44-6
pubmed: 2194010
Lancet. 1977 Nov 26;2(8048):1099-1102
pubmed: 73010
BMC Bioinformatics. 2011 Apr 28;12:124
pubmed: 21526987
Nucleic Acids Res. 2001 Jun 15;29(12):2607-18
pubmed: 11410670
Eur J Pediatr. 2001 Jun;160(6):385-91
pubmed: 11421422
J Clin Microbiol. 2015 Nov;53(11):3621-3
pubmed: 26292306
BMC Bioinformatics. 2010 Jan 05;11:7
pubmed: 20051126
J Hosp Infect. 1988 Aug;12(2):139-41
pubmed: 2905723
Infect Immun. 2001 Feb;69(2):706-11
pubmed: 11159958
Am J Clin Nutr. 2017 Sep;106(3):821-830
pubmed: 28659297
Anaerobe. 2015 Oct;35(Pt B):105-14
pubmed: 26363197
Clin Infect Dis. 2002 Sep 1;35(Suppl 1):S101-5
pubmed: 12173117
J Infect Dis. 1986 Aug;154(2):207-11
pubmed: 3722863
Clin Infect Dis. 2013 Oct;57(8):1094-102
pubmed: 23881150
Syst Biol. 2003 Oct;52(5):696-704
pubmed: 14530136
PLoS One. 2015 Apr 08;10(4):e0122684
pubmed: 25853427
Anaerobe. 2017 Dec;48:76-82
pubmed: 28739338
J Comput Biol. 2012 May;19(5):455-77
pubmed: 22506599
Clin Microbiol Infect. 2016 Jan;22(1):37-45
pubmed: 26493849
Clin Infect Dis. 2015 Feb 1;60(3):389-97
pubmed: 25344536
Anaerobe. 2017 Jun;45:65-70
pubmed: 28450145
Cell Rep. 2016 Mar 29;14(12):2912-24
pubmed: 26997279
J Clin Microbiol. 1992 Feb;30(2):514-6
pubmed: 1537928
Clin Microbiol Rev. 2015 Jan;28(1):208-36
pubmed: 25567228
Pediatr Res. 2004 Sep;56(3):366-70
pubmed: 15201403
Eur J Pediatr. 2008 Aug;167(8):891-5
pubmed: 17952466
Bioinformatics. 2017 Jan 1;33(1):128-129
pubmed: 27605102
Am J Med. 1996 Jan;100(1):32-40
pubmed: 8579084
J Hosp Infect. 2017 Mar;95(3):300-305
pubmed: 27988045

Auteurs

Michel Hosny (M)

Aix-Marseille Université UM63, Institut de Recherche pour le Développement IRD 198, Assistance Publique - Hôpitaux de Marseille (AP-HM), Microbes, Evolution, Phylogeny and Infection (MEΦI), Institut Hospitalo-Universitaire (IHU) - Méditerranée Infection, Marseille, France.

Jacques Yaacoub Bou Khalil (JY)

Aix-Marseille Université UM63, Institut de Recherche pour le Développement IRD 198, Assistance Publique - Hôpitaux de Marseille (AP-HM), Microbes, Evolution, Phylogeny and Infection (MEΦI), Institut Hospitalo-Universitaire (IHU) - Méditerranée Infection, Marseille, France.

Aurelia Caputo (A)

Aix-Marseille Université UM63, Institut de Recherche pour le Développement IRD 198, Assistance Publique - Hôpitaux de Marseille (AP-HM), Microbes, Evolution, Phylogeny and Infection (MEΦI), Institut Hospitalo-Universitaire (IHU) - Méditerranée Infection, Marseille, France.

Rita Abou Abdallah (RA)

Aix-Marseille Université UM63, Institut de Recherche pour le Développement IRD 198, Assistance Publique - Hôpitaux de Marseille (AP-HM), Vecteurs - Infections TROpicales et MÉditerrannéennes (VITROME), Service de Santé des Armées, Institut Hospitalo-Universitaire (IHU) - Méditerranée Infection, Marseille, France.

Anthony Levasseur (A)

Aix-Marseille Université UM63, Institut de Recherche pour le Développement IRD 198, Assistance Publique - Hôpitaux de Marseille (AP-HM), Microbes, Evolution, Phylogeny and Infection (MEΦI), Institut Hospitalo-Universitaire (IHU) - Méditerranée Infection, Marseille, France.

Philippe Colson (P)

Aix-Marseille Université UM63, Institut de Recherche pour le Développement IRD 198, Assistance Publique - Hôpitaux de Marseille (AP-HM), Microbes, Evolution, Phylogeny and Infection (MEΦI), Institut Hospitalo-Universitaire (IHU) - Méditerranée Infection, Marseille, France.

Nadim Cassir (N)

Aix-Marseille Université UM63, Institut de Recherche pour le Développement IRD 198, Assistance Publique - Hôpitaux de Marseille (AP-HM), Microbes, Evolution, Phylogeny and Infection (MEΦI), Institut Hospitalo-Universitaire (IHU) - Méditerranée Infection, Marseille, France.

Bernard La Scola (B)

Aix-Marseille Université UM63, Institut de Recherche pour le Développement IRD 198, Assistance Publique - Hôpitaux de Marseille (AP-HM), Microbes, Evolution, Phylogeny and Infection (MEΦI), Institut Hospitalo-Universitaire (IHU) - Méditerranée Infection, Marseille, France. bernard.la-scola@univ-amu.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH